Teva Qnasl Nasal Spray Recall: Failed Spray Content Uniformity
Teva recalls Qnasl nasal spray due to failed content uniformity in stability testing. This may affect spray consistency and medication effectiveness. Consumers should contact Teva for details.
Lower-risk recall
Failed Content Uniformity: Product was out of specification for spray content uniformity obtained during stability testing.
Contact the company
What happened, in plain English
Teva is recalling Qnasl nasal spray (40 mcg, 60 metered sprays) because it failed content uniformity tests during stability testing. This could mean inconsistent medication delivery, but the recall does not indicate a safety risk to users. Read more at govinfonow.com/recall/42266-teva-qnasl-nasal-spray-recall-failed-spray-content-uniformity.
Source Summary by GovInfoNow · govinfonow.com/recall/42266-teva-qnasl-nasal-spray-recall-failed-spray-content-uniformity · Updated October 9, 2026 · FDA enforcement record: FDA #D-0170-2017
Cite this page
“Teva Qnasl Nasal Spray Recall: Failed Spray Content Uniformity.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42266-teva-qnasl-nasal-spray-recall-failed-spray-content-uniformity. Based on FDA recall #D-0170-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0170-2017%22&limit=1).
Why it’s dangerous
The product failed content uniformity tests during stability testing. This means the spray may not deliver the correct medication dose consistently. However, the recall does not mention any safety risks like injury or serious health effects.
Who’s affected
People with prescriptions for Qnasl nasal spray from Teva. Those using the product for respiratory conditions may be affected if they have the specific lots mentioned.
How to tell if you have this one
Check for the product name Qnasl (beclomethasone dipropionate) Nasal Aerosol 40 Mcg, 60 Metered Sprays. Look for lot numbers 150096 (expiring 3/2017) or 150327 (expiring 10/2017).
- Brand
Teva- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class III- Status
Terminated- Distribution
Nationwide
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-0170-2017 | Qnasl (beclomethasone dipropionate) Nasal Aerosol 40 Mcg, 60 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-206-06 and 59310-206-08 (Physician Samples).; Lot #: 150096, Exp. 3/2017; Lot #: 150327, Exp. 10/2017 | 201, 234 Canisters |
| D-0171-2017 | Qnasl (beclomethasone dipropionate) Nasal Aerosol 80 Mcg, 50 Metered Sprays, Rx only, Manufactured for Teva Respiratory, LLC, Horsham, PA 19044, By: 3M Drug Delivery Systems, Northridge, CA 91324, NDC 59310-210-13.; Lot #: 150335, 150336, Exp. 4/2017 | N/A |
What to do — step by step
Check Product Details
Verify the lot number and expiration date on the product label to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 15 months after the firm started it.
- Firm started the recall
- FDA classified it Class III
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0170-2017 (November 1, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0170-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.